Ivosidenib Options

Outcomes of a 2nd comparative study had been described by Flinn et al. This is a stage III randomized Intergroup trial evaluating FC program versus FAMP alone in 278 sufferers acquiring their first chemotherapy regimen for B-CLL. Dosages of FC plan were similar to the first research. Skip to main
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15